benzonitrile has been researched along with piperazine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ahmad, A; Ahmad, B; Ahmad, M; Ali, A; Fatima, S; Muslim, M; Muthu, SA; Pissurlenkar, RRS; Shabbir, S | 1 |
Li, J; Li, Y; Li, Z; Peng, Z; Quan, Y; Tan, J; Wang, Y; Yang, B | 1 |
Cen, S; Ji, Y; Li, Y; Quan, Y; Wang, L; Wang, Y; Yang, B; Zhou, R | 1 |
3 other study(ies) available for benzonitrile and piperazine
Article | Year |
---|---|
The cocrystal of 3-((4-(3-isocyanobenzyl) piperazine-1-yl) methyl) benzonitrile with 5-hydroxy isophthalic acid prevents protofibril formation of serum albumin.
Topics: Amyloid; Humans; Hydroxy Acids; Nitriles; Phthalic Acids; Piperazine; Serum Albumin | 2022 |
Design, Synthesis, and Biological Evaluation of 2-((4-Bisarylmethyl-piperazin-1-yl)methyl)benzonitrile Derivatives as HCV Entry Inhibitors.
Topics: Administration, Oral; Animals; Antiviral Agents; Cell Line; Drug Design; Half-Life; Hepacivirus; Humans; Nitriles; Piperazine; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Viral Envelope Proteins; Virus Internalization | 2022 |
Identification of an N-phenylsulfonyl-2-(piperazin-1-yl)methyl-benzonitrile derivative as Zika virus entry inhibitor.
Topics: Antiviral Agents; HIV Fusion Inhibitors; Humans; Piperazine; Virus Internalization; Zika Virus; Zika Virus Infection | 2023 |